Group B Streptococcus (GBS) Infection Treatment Market, Global Outlook and Forecast 2022-2028
This report contains market size and forecasts of Group B Streptococcus (GBS) Infection Treatment in Global, including the following market information:
Global Group B Streptococcus (GBS) Infection Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Group B Streptococcus (GBS) Infection Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Prenatal-onset Gbs Disease Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Group B Streptococcus (GBS) Infection Treatment include Pfizer Inc., Alopexx Enterprises, LLC, Wellstat Vaccines LLC, Minervax ApS, Novartis and GlaxoSmithKline, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Group B Streptococcus (GBS) Infection Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Group B Streptococcus (GBS) Infection Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Group B Streptococcus (GBS) Infection Treatment Market Segment Percentages, by Type, 2021 (%)
Global Group B Streptococcus (GBS) Infection Treatment Market Segment Percentages, by Application, 2021 (%)
Global Group B Streptococcus (GBS) Infection Treatment Market Segment Percentages, By Region and Country, 2021 (%)
The report also provides analysis of leading market participants including:
Key companies Group B Streptococcus (GBS) Infection Treatment revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Group B Streptococcus (GBS) Infection Treatment revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Global Group B Streptococcus (GBS) Infection Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Group B Streptococcus (GBS) Infection Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Prenatal-onset Gbs Disease Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Group B Streptococcus (GBS) Infection Treatment include Pfizer Inc., Alopexx Enterprises, LLC, Wellstat Vaccines LLC, Minervax ApS, Novartis and GlaxoSmithKline, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Group B Streptococcus (GBS) Infection Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Group B Streptococcus (GBS) Infection Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Group B Streptococcus (GBS) Infection Treatment Market Segment Percentages, by Type, 2021 (%)
- Prenatal-onset Gbs Disease
- Early-onset Gbs Disease
- Late-onset Gbs Disease
Global Group B Streptococcus (GBS) Infection Treatment Market Segment Percentages, by Application, 2021 (%)
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Global Group B Streptococcus (GBS) Infection Treatment Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
The report also provides analysis of leading market participants including:
Key companies Group B Streptococcus (GBS) Infection Treatment revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Group B Streptococcus (GBS) Infection Treatment revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Pfizer Inc.
- Alopexx Enterprises, LLC
- Wellstat Vaccines LLC
- Minervax ApS
- Novartis
- GlaxoSmithKline
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS
1.1 Group B Streptococcus (GBS) Infection Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Group B Streptococcus (GBS) Infection Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL GROUP B STREPTOCOCCUS (GBS) INFECTION TREATMENT OVERALL MARKET SIZE
2.1 Global Group B Streptococcus (GBS) Infection Treatment Market Size: 2021 VS 2028
2.2 Global Group B Streptococcus (GBS) Infection Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 COMPANY LANDSCAPE
3.1 Top Group B Streptococcus (GBS) Infection Treatment Players in Global Market
3.2 Top Global Group B Streptococcus (GBS) Infection Treatment Companies Ranked by Revenue
3.3 Global Group B Streptococcus (GBS) Infection Treatment Revenue by Companies
3.4 Top 3 and Top 5 Group B Streptococcus (GBS) Infection Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies Group B Streptococcus (GBS) Infection Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Group B Streptococcus (GBS) Infection Treatment Players in Global Market
3.6.1 List of Global Tier 1 Group B Streptococcus (GBS) Infection Treatment Companies
3.6.2 List of Global Tier 2 and Tier 3 Group B Streptococcus (GBS) Infection Treatment Companies
4 MARKET SIGHTS BY PRODUCT
4.1 Overview
4.1.1 by Type - Global Group B Streptococcus (GBS) Infection Treatment Market Size Markets, 2021 & 2028
4.1.2 Prenatal-onset Gbs Disease
4.1.3 Early-onset Gbs Disease
4.1.4 Late-onset Gbs Disease
4.2 By Type - Global Group B Streptococcus (GBS) Infection Treatment Revenue & Forecasts
4.2.1 By Type - Global Group B Streptococcus (GBS) Infection Treatment Revenue, 2017-2022
4.2.2 By Type - Global Group B Streptococcus (GBS) Infection Treatment Revenue, 2023-2028
4.2.3 By Type - Global Group B Streptococcus (GBS) Infection Treatment Revenue Market Share, 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Group B Streptococcus (GBS) Infection Treatment Market Size, 2021 & 2028
5.1.2 Hospital Pharmacies
5.1.3 Retail Pharmacies
5.1.4 Online Pharmacies
5.2 By Application - Global Group B Streptococcus (GBS) Infection Treatment Revenue & Forecasts
5.2.1 By Application - Global Group B Streptococcus (GBS) Infection Treatment Revenue, 2017-2022
5.2.2 By Application - Global Group B Streptococcus (GBS) Infection Treatment Revenue, 2023-2028
5.2.3 By Application - Global Group B Streptococcus (GBS) Infection Treatment Revenue Market Share, 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Group B Streptococcus (GBS) Infection Treatment Market Size, 2021 & 2028
6.2 By Region - Global Group B Streptococcus (GBS) Infection Treatment Revenue & Forecasts
6.2.1 By Region - Global Group B Streptococcus (GBS) Infection Treatment Revenue, 2017-2022
6.2.2 By Region - Global Group B Streptococcus (GBS) Infection Treatment Revenue, 2023-2028
6.2.3 By Region - Global Group B Streptococcus (GBS) Infection Treatment Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Group B Streptococcus (GBS) Infection Treatment Revenue, 2017-2028
6.3.2 US Group B Streptococcus (GBS) Infection Treatment Market Size, 2017-2028
6.3.3 Canada Group B Streptococcus (GBS) Infection Treatment Market Size, 2017-2028
6.3.4 Mexico Group B Streptococcus (GBS) Infection Treatment Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Group B Streptococcus (GBS) Infection Treatment Revenue, 2017-2028
6.4.2 Germany Group B Streptococcus (GBS) Infection Treatment Market Size, 2017-2028
6.4.3 France Group B Streptococcus (GBS) Infection Treatment Market Size, 2017-2028
6.4.4 U.K. Group B Streptococcus (GBS) Infection Treatment Market Size, 2017-2028
6.4.5 Italy Group B Streptococcus (GBS) Infection Treatment Market Size, 2017-2028
6.4.6 Russia Group B Streptococcus (GBS) Infection Treatment Market Size, 2017-2028
6.4.7 Nordic Countries Group B Streptococcus (GBS) Infection Treatment Market Size, 2017-2028
6.4.8 Benelux Group B Streptococcus (GBS) Infection Treatment Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Group B Streptococcus (GBS) Infection Treatment Revenue, 2017-2028
6.5.2 China Group B Streptococcus (GBS) Infection Treatment Market Size, 2017-2028
6.5.3 Japan Group B Streptococcus (GBS) Infection Treatment Market Size, 2017-2028
6.5.4 South Korea Group B Streptococcus (GBS) Infection Treatment Market Size, 2017-2028
6.5.5 Southeast Asia Group B Streptococcus (GBS) Infection Treatment Market Size, 2017-2028
6.5.6 India Group B Streptococcus (GBS) Infection Treatment Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Group B Streptococcus (GBS) Infection Treatment Revenue, 2017-2028
6.6.2 Brazil Group B Streptococcus (GBS) Infection Treatment Market Size, 2017-2028
6.6.3 Argentina Group B Streptococcus (GBS) Infection Treatment Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Group B Streptococcus (GBS) Infection Treatment Revenue, 2017-2028
6.7.2 Turkey Group B Streptococcus (GBS) Infection Treatment Market Size, 2017-2028
6.7.3 Israel Group B Streptococcus (GBS) Infection Treatment Market Size, 2017-2028
6.7.4 Saudi Arabia Group B Streptococcus (GBS) Infection Treatment Market Size, 2017-2028
6.7.5 UAE Group B Streptococcus (GBS) Infection Treatment Market Size, 2017-2028
7 PLAYERS PROFILES
7.1 Pfizer Inc.
7.1.1 Pfizer Inc. Corporate Summary
7.1.2 Pfizer Inc. Business Overview
7.1.3 Pfizer Inc. Group B Streptococcus (GBS) Infection Treatment Major Product Offerings
7.1.4 Pfizer Inc. Group B Streptococcus (GBS) Infection Treatment Revenue in Global Market (2017-2022)
7.1.5 Pfizer Inc. Key News
7.2 Alopexx Enterprises, LLC
7.2.1 Alopexx Enterprises, LLC Corporate Summary
7.2.2 Alopexx Enterprises, LLC Business Overview
7.2.3 Alopexx Enterprises, LLC Group B Streptococcus (GBS) Infection Treatment Major Product Offerings
7.2.4 Alopexx Enterprises, LLC Group B Streptococcus (GBS) Infection Treatment Revenue in Global Market (2017-2022)
7.2.5 Alopexx Enterprises, LLC Key News
7.3 Wellstat Vaccines LLC
7.3.1 Wellstat Vaccines LLC Corporate Summary
7.3.2 Wellstat Vaccines LLC Business Overview
7.3.3 Wellstat Vaccines LLC Group B Streptococcus (GBS) Infection Treatment Major Product Offerings
7.3.4 Wellstat Vaccines LLC Group B Streptococcus (GBS) Infection Treatment Revenue in Global Market (2017-2022)
7.3.5 Wellstat Vaccines LLC Key News
7.4 Minervax ApS
7.4.1 Minervax ApS Corporate Summary
7.4.2 Minervax ApS Business Overview
7.4.3 Minervax ApS Group B Streptococcus (GBS) Infection Treatment Major Product Offerings
7.4.4 Minervax ApS Group B Streptococcus (GBS) Infection Treatment Revenue in Global Market (2017-2022)
7.4.5 Minervax ApS Key News
7.5 Novartis
7.5.1 Novartis Corporate Summary
7.5.2 Novartis Business Overview
7.5.3 Novartis Group B Streptococcus (GBS) Infection Treatment Major Product Offerings
7.5.4 Novartis Group B Streptococcus (GBS) Infection Treatment Revenue in Global Market (2017-2022)
7.5.5 Novartis Key News
7.6 GlaxoSmithKline
7.6.1 GlaxoSmithKline Corporate Summary
7.6.2 GlaxoSmithKline Business Overview
7.6.3 GlaxoSmithKline Group B Streptococcus (GBS) Infection Treatment Major Product Offerings
7.6.4 GlaxoSmithKline Group B Streptococcus (GBS) Infection Treatment Revenue in Global Market (2017-2022)
7.6.5 GlaxoSmithKline Key News
8 CONCLUSION
9 APPENDIX
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
1.1 Group B Streptococcus (GBS) Infection Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Group B Streptococcus (GBS) Infection Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL GROUP B STREPTOCOCCUS (GBS) INFECTION TREATMENT OVERALL MARKET SIZE
2.1 Global Group B Streptococcus (GBS) Infection Treatment Market Size: 2021 VS 2028
2.2 Global Group B Streptococcus (GBS) Infection Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 COMPANY LANDSCAPE
3.1 Top Group B Streptococcus (GBS) Infection Treatment Players in Global Market
3.2 Top Global Group B Streptococcus (GBS) Infection Treatment Companies Ranked by Revenue
3.3 Global Group B Streptococcus (GBS) Infection Treatment Revenue by Companies
3.4 Top 3 and Top 5 Group B Streptococcus (GBS) Infection Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies Group B Streptococcus (GBS) Infection Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Group B Streptococcus (GBS) Infection Treatment Players in Global Market
3.6.1 List of Global Tier 1 Group B Streptococcus (GBS) Infection Treatment Companies
3.6.2 List of Global Tier 2 and Tier 3 Group B Streptococcus (GBS) Infection Treatment Companies
4 MARKET SIGHTS BY PRODUCT
4.1 Overview
4.1.1 by Type - Global Group B Streptococcus (GBS) Infection Treatment Market Size Markets, 2021 & 2028
4.1.2 Prenatal-onset Gbs Disease
4.1.3 Early-onset Gbs Disease
4.1.4 Late-onset Gbs Disease
4.2 By Type - Global Group B Streptococcus (GBS) Infection Treatment Revenue & Forecasts
4.2.1 By Type - Global Group B Streptococcus (GBS) Infection Treatment Revenue, 2017-2022
4.2.2 By Type - Global Group B Streptococcus (GBS) Infection Treatment Revenue, 2023-2028
4.2.3 By Type - Global Group B Streptococcus (GBS) Infection Treatment Revenue Market Share, 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Group B Streptococcus (GBS) Infection Treatment Market Size, 2021 & 2028
5.1.2 Hospital Pharmacies
5.1.3 Retail Pharmacies
5.1.4 Online Pharmacies
5.2 By Application - Global Group B Streptococcus (GBS) Infection Treatment Revenue & Forecasts
5.2.1 By Application - Global Group B Streptococcus (GBS) Infection Treatment Revenue, 2017-2022
5.2.2 By Application - Global Group B Streptococcus (GBS) Infection Treatment Revenue, 2023-2028
5.2.3 By Application - Global Group B Streptococcus (GBS) Infection Treatment Revenue Market Share, 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Group B Streptococcus (GBS) Infection Treatment Market Size, 2021 & 2028
6.2 By Region - Global Group B Streptococcus (GBS) Infection Treatment Revenue & Forecasts
6.2.1 By Region - Global Group B Streptococcus (GBS) Infection Treatment Revenue, 2017-2022
6.2.2 By Region - Global Group B Streptococcus (GBS) Infection Treatment Revenue, 2023-2028
6.2.3 By Region - Global Group B Streptococcus (GBS) Infection Treatment Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Group B Streptococcus (GBS) Infection Treatment Revenue, 2017-2028
6.3.2 US Group B Streptococcus (GBS) Infection Treatment Market Size, 2017-2028
6.3.3 Canada Group B Streptococcus (GBS) Infection Treatment Market Size, 2017-2028
6.3.4 Mexico Group B Streptococcus (GBS) Infection Treatment Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Group B Streptococcus (GBS) Infection Treatment Revenue, 2017-2028
6.4.2 Germany Group B Streptococcus (GBS) Infection Treatment Market Size, 2017-2028
6.4.3 France Group B Streptococcus (GBS) Infection Treatment Market Size, 2017-2028
6.4.4 U.K. Group B Streptococcus (GBS) Infection Treatment Market Size, 2017-2028
6.4.5 Italy Group B Streptococcus (GBS) Infection Treatment Market Size, 2017-2028
6.4.6 Russia Group B Streptococcus (GBS) Infection Treatment Market Size, 2017-2028
6.4.7 Nordic Countries Group B Streptococcus (GBS) Infection Treatment Market Size, 2017-2028
6.4.8 Benelux Group B Streptococcus (GBS) Infection Treatment Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Group B Streptococcus (GBS) Infection Treatment Revenue, 2017-2028
6.5.2 China Group B Streptococcus (GBS) Infection Treatment Market Size, 2017-2028
6.5.3 Japan Group B Streptococcus (GBS) Infection Treatment Market Size, 2017-2028
6.5.4 South Korea Group B Streptococcus (GBS) Infection Treatment Market Size, 2017-2028
6.5.5 Southeast Asia Group B Streptococcus (GBS) Infection Treatment Market Size, 2017-2028
6.5.6 India Group B Streptococcus (GBS) Infection Treatment Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Group B Streptococcus (GBS) Infection Treatment Revenue, 2017-2028
6.6.2 Brazil Group B Streptococcus (GBS) Infection Treatment Market Size, 2017-2028
6.6.3 Argentina Group B Streptococcus (GBS) Infection Treatment Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Group B Streptococcus (GBS) Infection Treatment Revenue, 2017-2028
6.7.2 Turkey Group B Streptococcus (GBS) Infection Treatment Market Size, 2017-2028
6.7.3 Israel Group B Streptococcus (GBS) Infection Treatment Market Size, 2017-2028
6.7.4 Saudi Arabia Group B Streptococcus (GBS) Infection Treatment Market Size, 2017-2028
6.7.5 UAE Group B Streptococcus (GBS) Infection Treatment Market Size, 2017-2028
7 PLAYERS PROFILES
7.1 Pfizer Inc.
7.1.1 Pfizer Inc. Corporate Summary
7.1.2 Pfizer Inc. Business Overview
7.1.3 Pfizer Inc. Group B Streptococcus (GBS) Infection Treatment Major Product Offerings
7.1.4 Pfizer Inc. Group B Streptococcus (GBS) Infection Treatment Revenue in Global Market (2017-2022)
7.1.5 Pfizer Inc. Key News
7.2 Alopexx Enterprises, LLC
7.2.1 Alopexx Enterprises, LLC Corporate Summary
7.2.2 Alopexx Enterprises, LLC Business Overview
7.2.3 Alopexx Enterprises, LLC Group B Streptococcus (GBS) Infection Treatment Major Product Offerings
7.2.4 Alopexx Enterprises, LLC Group B Streptococcus (GBS) Infection Treatment Revenue in Global Market (2017-2022)
7.2.5 Alopexx Enterprises, LLC Key News
7.3 Wellstat Vaccines LLC
7.3.1 Wellstat Vaccines LLC Corporate Summary
7.3.2 Wellstat Vaccines LLC Business Overview
7.3.3 Wellstat Vaccines LLC Group B Streptococcus (GBS) Infection Treatment Major Product Offerings
7.3.4 Wellstat Vaccines LLC Group B Streptococcus (GBS) Infection Treatment Revenue in Global Market (2017-2022)
7.3.5 Wellstat Vaccines LLC Key News
7.4 Minervax ApS
7.4.1 Minervax ApS Corporate Summary
7.4.2 Minervax ApS Business Overview
7.4.3 Minervax ApS Group B Streptococcus (GBS) Infection Treatment Major Product Offerings
7.4.4 Minervax ApS Group B Streptococcus (GBS) Infection Treatment Revenue in Global Market (2017-2022)
7.4.5 Minervax ApS Key News
7.5 Novartis
7.5.1 Novartis Corporate Summary
7.5.2 Novartis Business Overview
7.5.3 Novartis Group B Streptococcus (GBS) Infection Treatment Major Product Offerings
7.5.4 Novartis Group B Streptococcus (GBS) Infection Treatment Revenue in Global Market (2017-2022)
7.5.5 Novartis Key News
7.6 GlaxoSmithKline
7.6.1 GlaxoSmithKline Corporate Summary
7.6.2 GlaxoSmithKline Business Overview
7.6.3 GlaxoSmithKline Group B Streptococcus (GBS) Infection Treatment Major Product Offerings
7.6.4 GlaxoSmithKline Group B Streptococcus (GBS) Infection Treatment Revenue in Global Market (2017-2022)
7.6.5 GlaxoSmithKline Key News
8 CONCLUSION
9 APPENDIX
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES
Table 1. Group B Streptococcus (GBS) Infection Treatment Market Opportunities & Trends in Global Market
Table 2. Group B Streptococcus (GBS) Infection Treatment Market Drivers in Global Market
Table 3. Group B Streptococcus (GBS) Infection Treatment Market Restraints in Global Market
Table 4. Key Players of Group B Streptococcus (GBS) Infection Treatment in Global Market
Table 5. Top Group B Streptococcus (GBS) Infection Treatment Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Group B Streptococcus (GBS) Infection Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Group B Streptococcus (GBS) Infection Treatment Revenue Share by Companies, 2017-2022
Table 8. Global Companies Group B Streptococcus (GBS) Infection Treatment Product Type
Table 9. List of Global Tier 1 Group B Streptococcus (GBS) Infection Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Group B Streptococcus (GBS) Infection Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Group B Streptococcus (GBS) Infection Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Group B Streptococcus (GBS) Infection Treatment Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Group B Streptococcus (GBS) Infection Treatment Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Group B Streptococcus (GBS) Infection Treatment Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Group B Streptococcus (GBS) Infection Treatment Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Group B Streptococcus (GBS) Infection Treatment Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Group B Streptococcus (GBS) Infection Treatment Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Group B Streptococcus (GBS) Infection Treatment Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Group B Streptococcus (GBS) Infection Treatment Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Group B Streptococcus (GBS) Infection Treatment Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Group B Streptococcus (GBS) Infection Treatment Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Group B Streptococcus (GBS) Infection Treatment Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Group B Streptococcus (GBS) Infection Treatment Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Group B Streptococcus (GBS) Infection Treatment Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Group B Streptococcus (GBS) Infection Treatment Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Group B Streptococcus (GBS) Infection Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Group B Streptococcus (GBS) Infection Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Group B Streptococcus (GBS) Infection Treatment Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Group B Streptococcus (GBS) Infection Treatment Revenue, (US$, Mn), 2023-2028
Table 30. Pfizer Inc. Corporate Summary
Table 31. Pfizer Inc. Group B Streptococcus (GBS) Infection Treatment Product Offerings
Table 32. Pfizer Inc. Group B Streptococcus (GBS) Infection Treatment Revenue (US$, Mn), (2017-2022)
Table 33. Alopexx Enterprises, LLC Corporate Summary
Table 34. Alopexx Enterprises, LLC Group B Streptococcus (GBS) Infection Treatment Product Offerings
Table 35. Alopexx Enterprises, LLC Group B Streptococcus (GBS) Infection Treatment Revenue (US$, Mn), (2017-2022)
Table 36. Wellstat Vaccines LLC Corporate Summary
Table 37. Wellstat Vaccines LLC Group B Streptococcus (GBS) Infection Treatment Product Offerings
Table 38. Wellstat Vaccines LLC Group B Streptococcus (GBS) Infection Treatment Revenue (US$, Mn), (2017-2022)
Table 39. Minervax ApS Corporate Summary
Table 40. Minervax ApS Group B Streptococcus (GBS) Infection Treatment Product Offerings
Table 41. Minervax ApS Group B Streptococcus (GBS) Infection Treatment Revenue (US$, Mn), (2017-2022)
Table 42. Novartis Corporate Summary
Table 43. Novartis Group B Streptococcus (GBS) Infection Treatment Product Offerings
Table 44. Novartis Group B Streptococcus (GBS) Infection Treatment Revenue (US$, Mn), (2017-2022)
Table 45. GlaxoSmithKline Corporate Summary
Table 46. GlaxoSmithKline Group B Streptococcus (GBS) Infection Treatment Product Offerings
Table 47. GlaxoSmithKline Group B Streptococcus (GBS) Infection Treatment Revenue (US$, Mn), (2017-2022)
Table 1. Group B Streptococcus (GBS) Infection Treatment Market Opportunities & Trends in Global Market
Table 2. Group B Streptococcus (GBS) Infection Treatment Market Drivers in Global Market
Table 3. Group B Streptococcus (GBS) Infection Treatment Market Restraints in Global Market
Table 4. Key Players of Group B Streptococcus (GBS) Infection Treatment in Global Market
Table 5. Top Group B Streptococcus (GBS) Infection Treatment Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Group B Streptococcus (GBS) Infection Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Group B Streptococcus (GBS) Infection Treatment Revenue Share by Companies, 2017-2022
Table 8. Global Companies Group B Streptococcus (GBS) Infection Treatment Product Type
Table 9. List of Global Tier 1 Group B Streptococcus (GBS) Infection Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Group B Streptococcus (GBS) Infection Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Group B Streptococcus (GBS) Infection Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Group B Streptococcus (GBS) Infection Treatment Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Group B Streptococcus (GBS) Infection Treatment Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Group B Streptococcus (GBS) Infection Treatment Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Group B Streptococcus (GBS) Infection Treatment Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Group B Streptococcus (GBS) Infection Treatment Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Group B Streptococcus (GBS) Infection Treatment Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Group B Streptococcus (GBS) Infection Treatment Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Group B Streptococcus (GBS) Infection Treatment Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Group B Streptococcus (GBS) Infection Treatment Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Group B Streptococcus (GBS) Infection Treatment Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Group B Streptococcus (GBS) Infection Treatment Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Group B Streptococcus (GBS) Infection Treatment Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Group B Streptococcus (GBS) Infection Treatment Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Group B Streptococcus (GBS) Infection Treatment Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Group B Streptococcus (GBS) Infection Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Group B Streptococcus (GBS) Infection Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Group B Streptococcus (GBS) Infection Treatment Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Group B Streptococcus (GBS) Infection Treatment Revenue, (US$, Mn), 2023-2028
Table 30. Pfizer Inc. Corporate Summary
Table 31. Pfizer Inc. Group B Streptococcus (GBS) Infection Treatment Product Offerings
Table 32. Pfizer Inc. Group B Streptococcus (GBS) Infection Treatment Revenue (US$, Mn), (2017-2022)
Table 33. Alopexx Enterprises, LLC Corporate Summary
Table 34. Alopexx Enterprises, LLC Group B Streptococcus (GBS) Infection Treatment Product Offerings
Table 35. Alopexx Enterprises, LLC Group B Streptococcus (GBS) Infection Treatment Revenue (US$, Mn), (2017-2022)
Table 36. Wellstat Vaccines LLC Corporate Summary
Table 37. Wellstat Vaccines LLC Group B Streptococcus (GBS) Infection Treatment Product Offerings
Table 38. Wellstat Vaccines LLC Group B Streptococcus (GBS) Infection Treatment Revenue (US$, Mn), (2017-2022)
Table 39. Minervax ApS Corporate Summary
Table 40. Minervax ApS Group B Streptococcus (GBS) Infection Treatment Product Offerings
Table 41. Minervax ApS Group B Streptococcus (GBS) Infection Treatment Revenue (US$, Mn), (2017-2022)
Table 42. Novartis Corporate Summary
Table 43. Novartis Group B Streptococcus (GBS) Infection Treatment Product Offerings
Table 44. Novartis Group B Streptococcus (GBS) Infection Treatment Revenue (US$, Mn), (2017-2022)
Table 45. GlaxoSmithKline Corporate Summary
Table 46. GlaxoSmithKline Group B Streptococcus (GBS) Infection Treatment Product Offerings
Table 47. GlaxoSmithKline Group B Streptococcus (GBS) Infection Treatment Revenue (US$, Mn), (2017-2022)
LIST OF FIGURES
Figure 1. Group B Streptococcus (GBS) Infection Treatment Segment by Type in 2021
Figure 2. Group B Streptococcus (GBS) Infection Treatment Segment by Application in 2021
Figure 3. Global Group B Streptococcus (GBS) Infection Treatment Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Group B Streptococcus (GBS) Infection Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Group B Streptococcus (GBS) Infection Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Group B Streptococcus (GBS) Infection Treatment Revenue in 2021
Figure 8. By Type - Global Group B Streptococcus (GBS) Infection Treatment Revenue Market Share, 2017-2028
Figure 9. By Application - Global Group B Streptococcus (GBS) Infection Treatment Revenue Market Share, 2017-2028
Figure 10. By Region - Global Group B Streptococcus (GBS) Infection Treatment Revenue Market Share, 2017-2028
Figure 11. By Country - North America Group B Streptococcus (GBS) Infection Treatment Revenue Market Share, 2017-2028
Figure 12. US Group B Streptococcus (GBS) Infection Treatment Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Group B Streptococcus (GBS) Infection Treatment Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Group B Streptococcus (GBS) Infection Treatment Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Group B Streptococcus (GBS) Infection Treatment Revenue Market Share, 2017-2028
Figure 16. Germany Group B Streptococcus (GBS) Infection Treatment Revenue, (US$, Mn), 2017-2028
Figure 17. France Group B Streptococcus (GBS) Infection Treatment Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Group B Streptococcus (GBS) Infection Treatment Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Group B Streptococcus (GBS) Infection Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Group B Streptococcus (GBS) Infection Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Group B Streptococcus (GBS) Infection Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Group B Streptococcus (GBS) Infection Treatment Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Group B Streptococcus (GBS) Infection Treatment Revenue Market Share, 2017-2028
Figure 24. China Group B Streptococcus (GBS) Infection Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Group B Streptococcus (GBS) Infection Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Group B Streptococcus (GBS) Infection Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Group B Streptococcus (GBS) Infection Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. India Group B Streptococcus (GBS) Infection Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Group B Streptococcus (GBS) Infection Treatment Revenue Market Share, 2017-2028
Figure 30. Brazil Group B Streptococcus (GBS) Infection Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Group B Streptococcus (GBS) Infection Treatment Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Group B Streptococcus (GBS) Infection Treatment Revenue Market Share, 2017-2028
Figure 33. Turkey Group B Streptococcus (GBS) Infection Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Group B Streptococcus (GBS) Infection Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Group B Streptococcus (GBS) Infection Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Group B Streptococcus (GBS) Infection Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. Pfizer Inc. Group B Streptococcus (GBS) Infection Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Alopexx Enterprises, LLC Group B Streptococcus (GBS) Infection Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Wellstat Vaccines LLC Group B Streptococcus (GBS) Infection Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Minervax ApS Group B Streptococcus (GBS) Infection Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Novartis Group B Streptococcus (GBS) Infection Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. GlaxoSmithKline Group B Streptococcus (GBS) Infection Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 1. Group B Streptococcus (GBS) Infection Treatment Segment by Type in 2021
Figure 2. Group B Streptococcus (GBS) Infection Treatment Segment by Application in 2021
Figure 3. Global Group B Streptococcus (GBS) Infection Treatment Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Group B Streptococcus (GBS) Infection Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Group B Streptococcus (GBS) Infection Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Group B Streptococcus (GBS) Infection Treatment Revenue in 2021
Figure 8. By Type - Global Group B Streptococcus (GBS) Infection Treatment Revenue Market Share, 2017-2028
Figure 9. By Application - Global Group B Streptococcus (GBS) Infection Treatment Revenue Market Share, 2017-2028
Figure 10. By Region - Global Group B Streptococcus (GBS) Infection Treatment Revenue Market Share, 2017-2028
Figure 11. By Country - North America Group B Streptococcus (GBS) Infection Treatment Revenue Market Share, 2017-2028
Figure 12. US Group B Streptococcus (GBS) Infection Treatment Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Group B Streptococcus (GBS) Infection Treatment Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Group B Streptococcus (GBS) Infection Treatment Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Group B Streptococcus (GBS) Infection Treatment Revenue Market Share, 2017-2028
Figure 16. Germany Group B Streptococcus (GBS) Infection Treatment Revenue, (US$, Mn), 2017-2028
Figure 17. France Group B Streptococcus (GBS) Infection Treatment Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Group B Streptococcus (GBS) Infection Treatment Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Group B Streptococcus (GBS) Infection Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Group B Streptococcus (GBS) Infection Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Group B Streptococcus (GBS) Infection Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Group B Streptococcus (GBS) Infection Treatment Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Group B Streptococcus (GBS) Infection Treatment Revenue Market Share, 2017-2028
Figure 24. China Group B Streptococcus (GBS) Infection Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Group B Streptococcus (GBS) Infection Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Group B Streptococcus (GBS) Infection Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Group B Streptococcus (GBS) Infection Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. India Group B Streptococcus (GBS) Infection Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Group B Streptococcus (GBS) Infection Treatment Revenue Market Share, 2017-2028
Figure 30. Brazil Group B Streptococcus (GBS) Infection Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Group B Streptococcus (GBS) Infection Treatment Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Group B Streptococcus (GBS) Infection Treatment Revenue Market Share, 2017-2028
Figure 33. Turkey Group B Streptococcus (GBS) Infection Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Group B Streptococcus (GBS) Infection Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Group B Streptococcus (GBS) Infection Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Group B Streptococcus (GBS) Infection Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. Pfizer Inc. Group B Streptococcus (GBS) Infection Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Alopexx Enterprises, LLC Group B Streptococcus (GBS) Infection Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Wellstat Vaccines LLC Group B Streptococcus (GBS) Infection Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Minervax ApS Group B Streptococcus (GBS) Infection Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Novartis Group B Streptococcus (GBS) Infection Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. GlaxoSmithKline Group B Streptococcus (GBS) Infection Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
